ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 90 filers reported holding ALX ONCOLOGY HLDGS INC in Q4 2020. The put-call ratio across all filers is 0.71 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $178,540 | -63.2% | 39,500 | -8.1% | 0.00% | – |
| Q4 2022 | $484,610 | +17.6% | 43,000 | 0.0% | 0.00% | – |
| Q3 2022 | $412,000 | +18.4% | 43,000 | 0.0% | 0.00% | – |
| Q2 2022 | $348,000 | +7.4% | 43,000 | +124.0% | 0.00% | – |
| Q1 2022 | $324,000 | -14.7% | 19,200 | +8.5% | 0.00% | – |
| Q4 2021 | $380,000 | -70.9% | 17,700 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,307,000 | +35.0% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $968,000 | -27.9% | 17,700 | -2.7% | 0.00% | 0.0% |
| Q1 2021 | $1,342,000 | -6.8% | 18,200 | +9.0% | 0.00% | 0.0% |
| Q4 2020 | $1,440,000 | – | 16,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
| Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
| Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
| Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
| Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
| Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
| Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
| Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
| Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |